Portico hits noninferiority, but safety looks doubtful. Abbott might want to prioritise a different approach.
Intuitive Surgical makes the most money per employee – but the title of “most improved” goes to Philips.
The overall rate of device approvals in 2019 is holding steady on last year – but the types of approvals are different.
The medtech market’s fast growth and unfettered demand attracts investment groups, while hospital suppliers consolidate.
The recent disappointing sales of drug-coated devices for peripheral arterial disease look likely to become the norm.
A poor quarter is followed by an acquisition, but is it big enough?
Transvaginal mesh implants are banned in the US, but remain a possibility in Europe.
The battle for dominance of the transcatheter aortic valve market has shifted to new territory. And once again, Edwards Lifesciences is winning.
Transcatheter mitral valve replacement is wrenching the spotlight away from the repair devices that grabbed the headlines last summer.